06-15-2026ASK THE EXPERTS

Why VCs are suddenly obsessed with women’s health

Women’s health companies were long viewed as niche businesses despite serving enormous markets. Now that’s beginning to change.

[Source Image: Adobe Stock]

Over the next two decades, roughly $124 trillion is expected to change hands in what analysts describe as the largest intergenerational wealth transfer in history. A growing share of that wealth is moving to women through inheritance, entrepreneurship, and rising lifetime earnings. At the same time, healthcare is confronting another reality: Much of modern medicine was built around male biology. Those two shifts are beginning to collide.

For decades, women were routinely excluded from clinical trials. In the United States, women were not required to be included in federally funded studies until 1993. Drug........

© Fast Company